News and Trends 20 Aug 2020 Is Hepatitis D Healthcare Being Overlooked? Despite the recent EU approval of the first hepatitis D treatment, low public awareness remains an obstacle to tackling this aggressive infection. Earlier this month, the peptide drug Hepcludex became the first drug greenlit for hepatitis D treatment in Europe. This was a conditional market authorization granted to the German company MYR Pharmaceuticals based on […] August 20, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jun 2019 Dutch Biotech Boosts Hepatitis B Vaccine Effectiveness Phase II results from Dutch biotech CyTuVax show its enhanced hepatitis B vaccine reduces non-responders by 13%. Around 15% of people receiving vaccines for hepatitis B fail to produce antibodies that protect them against the infection. These non-responders are often given more injections of the vaccine in an attempt to trigger the immune system, but […] June 18, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2019 Austrian Biopharma Reaches First HIV Vaccine Milestone Hookipa Pharma has reached its first milestone in a partnership deal with US-based CAR T pioneers Gilead Sciences to develop an HIV vaccine using the Austrian company’s arenavirus-based technology. Hookipa’s lead candidate is a prophylactic vaccine for cytomegalovirus, a common infection that can be dangerous in people with weak immune systems, such as those with […] January 3, 2019 - 2 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 2 Jul 2018 New Blood Test Brings Cheaper Hepatitis B Diagnosis European and African researchers are developing a hepatitis B blood test that could help identify patients in Africa’s poorest regions who need immediate treatment. While treatments for hepatitis B are now available at a low cost, managing treatments effectively is still a challenge in Africa. This is because some patients who are infected with the […] July 2, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 19 Feb 2018 Organ-on-a-Chip Technology Used to Spot New Hepatitis B Drug Targets Scientists in London are the first in the world to test how pathogens like the hepatitis B virus interact with artificial human organs. Researchers at Imperial College London have used artificial human organs, or organs-on-chips, to replicate the make-up and physiology of the cells in whole organs. The study, published in Nature Communications, shows how the […] February 19, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 23 Oct 2017 Transgene‘s Hepatitis B Vaccine Does the Business at Phase I The French biotech‘s hepatitis B vaccine has demonstrated good efficacy and safety, suggesting it could provide effective protection from the virus. Biotech veteran, Transgene, specializes in viral-based immunotherapies for cancers and infectious diseases. One of its targets, hepatitis B, is a potentially fatal liver infection caused by the hepatitis B virus (HBV). Today, it has […] October 23, 2017 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 14 Jun 2017 French Hepatitis Cure is on Track with Positive Phase I Results Enyo Pharma has announced that its lead candidate EYP001, indicated for the treatment of hepatitis B, successfully cleared a Phase Ia trial. Enyo Pharma is one of the hottest biotechs in Lyon that is developing new treatments against viruses, including hepatitis B or severe influenza infections. Its key asset, EYP001, is a farnesoid X receptor (FXR) agonist indicated […] June 14, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 23 Dec 2016 The 8 Biggest Biotech Medical Fails of 2016 in Europe Although 2016 has brought plenty of good news in medical advances, biotech is an industry where failure is part of the game. Here’s a list of medical fails in biotech to learn from this year. Unfortunately, 2016 has not been a good year for pharma, with revenues in the top companies falling, the lowest number […] December 23, 2016 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email